Essex Bio-Technology Limited (1061.HK)
1061.HK Stock Price Chart
Explore Essex Bio-Technology Limited interactive price chart. Choose custom timeframes to analyze 1061.HK price movements and trends.
1061.HK Company Profile
Discover essential business fundamentals and corporate details for Essex Bio-Technology Limited (1061.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
27 Jun 2001
Employees
1.45K
Website
https://www.essexbio.comCEO
Mia Je Ngiam
Description
Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally. The company operates through Ophthalmic Products and Surgical Products segments. It researches and develops basic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration. The company offers Beifushu series, such as Beifushu eye drops, Beifushu eye gel, and Beifushu unit-dose eye drops; Tobramycin eye drops, Levofloxacin eye drops, and Sodium Hyaluronate eye drops, as well as Iodized Lecithin Capsules. It also provides Beifuji sprays and lyophilized powder, and Beifuxin gels for use in burn and scald wounds, acute wounds, surgical incisions, chronic wounds, skin grafting, and other applications. In addition, it offers ophthalmic and surgical products from third parties. Further, the company offers Carisolv dental caries removal gel; and Yi Xue An Granules. It has license agreements with Mitotech S.A. and Mitotech LLC. The company was founded in 1990 and is headquartered in Zhuhai, China.
1061.HK Financial Timeline
Browse a chronological timeline of Essex Bio-Technology Limited corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 8 Sept 2025
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend will be paid on 23 Sept 2025.
Earnings released on 26 Aug 2025
EPS came in at $0.29 , while revenue for the quarter reached $876.54M .
Dividend declared on 23 May 2025
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 9 Jun 2025.
Earnings released on 26 Mar 2025
EPS came in at $0.26 , while revenue for the quarter reached $858.19M .
Dividend declared on 9 Sept 2024
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 24 Sept 2024.
Earnings released on 26 Aug 2024
EPS came in at $0.27 , while revenue for the quarter reached $811.63M .
Dividend declared on 30 May 2024
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 17 Jun 2024.
Earnings released on 18 Mar 2024
EPS came in at $0.18 , while revenue for the quarter reached $807.20M , missing expectations by -25.80%.
Dividend declared on 29 Aug 2023
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 13 Sept 2023.
Earnings released on 16 Aug 2023
EPS came in at $0.28 , while revenue for the quarter reached $899.36M , missing expectations by -17.33%.
Dividend declared on 13 Jun 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 29 Jun 2023.
Earnings released on 8 Mar 2023
EPS came in at $0.14 , while revenue for the quarter reached $661.89M , missing expectations by -39.16%.
Dividend declared on 5 Sept 2022
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 21 Sept 2022.
Earnings released on 23 Aug 2022
EPS came in at $0.23 , while revenue for the quarter reached $655.83M , missing expectations by -39.72%.
Dividend declared on 4 May 2022
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 20 May 2022.
Earnings released on 31 Dec 2021
EPS came in at $0.31 , while revenue for the quarter reached $900.29M .
Dividend declared on 30 Aug 2021
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 14 Sept 2021.
Earnings released on 30 Jun 2021
EPS came in at $0.27 , while revenue for the quarter reached $737.37M .
Dividend declared on 14 May 2021
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 1 Jun 2021.
Earnings released on 31 Dec 2020
EPS came in at $0.28 , while revenue for the quarter reached $654.28M .
1061.HK Stock Performance
Access detailed 1061.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.